MedTrace Logo

Health Status, Quality of Life and Function in Survivors After Radical Treatment for Prostate Cancer. Part I and IIA

NCT04863352 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 657

Last updated 2023-11-18

No results posted yet for this study

Summary

In this study, addressing prostate cancer survivors, i.e. men who received potentially curative (radical) treatment two to six years ago, we will investigate if older age at time of treatment is a detrimental factor with respect to long-term quality of life (Qol), health, and function. We will also compare QoL, health and function between the prostate cancer survivors and matched population based cohorts, and thereby provide realistic information on the long-term impact of radical prostate cancer treatment

Conditions

Sponsors & Collaborators

  • Norwegian University of Science and Technology

    collaborator OTHER

  • Sykehuset Innlandet HF

    lead OTHER

Principal Investigators

  • Marit Slaaen, PhD · Sykehuset Innlandet HF

  • Ola Berger Christiansen, PhD · Sykehuset Innlandet HF

Eligibility

Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-05-04
Primary Completion
2021-11-19
Completion
2021-11-19

Countries

  • Norway

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04863352 on ClinicalTrials.gov